Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 James Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 James Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> New Vaccine Approach May Be Needed As ‘Natural’ Antibodies Fail to Recognise COVID-19 Variant in South Africa 21/01/2021 Kerry Cullinan CAPE TOWN – Scientists are concerned that antibodies that could detect SARS-CoV-2 in South Africa’s first wave will be less effective against a virus variant that first emerged here and is known as 501Y.V2. What’s worse, they still don’t know if brand new COVID-19 vaccines will work against the variant – which is deemed to […] Continue reading -> Pandemic Perils: How Battling One Deadly Disease May Intensify Risks From Others 21/01/2021 Jamie Bay Nishi The demands of fighting the COVID-19 pandemic are draining resources from global health research and development (R&D) programs and disrupting clinical trials and other work, presenting a potential post-pandemic scenario of a world more vulnerable to a host of infectious threats. That’s what our organization, the Global Health Technologies Coalition (GHTC), learned after conducting extensive, […] Continue reading -> ‘Bilateral Deals’ Confound COVAX Vaccine Delivery Plans; Independent Panel Slams Global & WHO Pandemic Response 18/01/2021 Kerry Cullinan “Escalating bilateral deals” between pharmaceutical companies and World Health Organization (WHO) member states have complicated the global body’s vaccine delivery platform, the COVAX Facility, a number of top WHO officials told the WHO’s Executive Board yesterday in the opening day of the EB’s 148th session, which focused largely on the pandemic. “Countries with bilateral deals […] Continue reading -> COVID-19 Cases Spike In Brazil As New Variant Spreads, While WHO Says No Need For ‘Vaccine Passport’ Yet 15/01/2021 Madeleine Hoecklin & Kerry Cullinan Many areas of Brazil, particularly Manaus, are experiencing worsening COVID-19 outbreaks and extremely high levels of infections, amidst news of a new variant that is spreading in the country. Brazil joins countries around the world – including those in Europe, the Americas, and some parts of Africa – that are seeing spikes in cases and […] Continue reading -> COVID-19 Infection Provides Temporary Immunity, Though Not From Transmission, Says Study 15/01/2021 Raisa Santos Past COVID-19 infection may provide immunity for several months, but still leaves risk of transmission to others, a Public Health England (PHE) study has found. “This means even if you believe you already had the disease and are protected, you can be reassured it is highly unlikely you will develop severe infections but there is […] Continue reading -> Hundreds of Victims of Bhopal Gas Leak Tragedy Recruited To India’s Covaxin Clinical Trials – Civil Society Groups Say 14/01/2021 Menaka Rao DELHI, INDIA – In the last week of December 2020, Chanda Devi heard a truck roll into her neighborhood in North Bhopal, Central India. Residents were called outside by a voice, booming through loudspeakers. They were eligible to collect Rs 750 (about US$10) to receive a “corona vaccine”. The people said that they were recruiters, […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 James Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 James Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> New Vaccine Approach May Be Needed As ‘Natural’ Antibodies Fail to Recognise COVID-19 Variant in South Africa 21/01/2021 Kerry Cullinan CAPE TOWN – Scientists are concerned that antibodies that could detect SARS-CoV-2 in South Africa’s first wave will be less effective against a virus variant that first emerged here and is known as 501Y.V2. What’s worse, they still don’t know if brand new COVID-19 vaccines will work against the variant – which is deemed to […] Continue reading -> Pandemic Perils: How Battling One Deadly Disease May Intensify Risks From Others 21/01/2021 Jamie Bay Nishi The demands of fighting the COVID-19 pandemic are draining resources from global health research and development (R&D) programs and disrupting clinical trials and other work, presenting a potential post-pandemic scenario of a world more vulnerable to a host of infectious threats. That’s what our organization, the Global Health Technologies Coalition (GHTC), learned after conducting extensive, […] Continue reading -> ‘Bilateral Deals’ Confound COVAX Vaccine Delivery Plans; Independent Panel Slams Global & WHO Pandemic Response 18/01/2021 Kerry Cullinan “Escalating bilateral deals” between pharmaceutical companies and World Health Organization (WHO) member states have complicated the global body’s vaccine delivery platform, the COVAX Facility, a number of top WHO officials told the WHO’s Executive Board yesterday in the opening day of the EB’s 148th session, which focused largely on the pandemic. “Countries with bilateral deals […] Continue reading -> COVID-19 Cases Spike In Brazil As New Variant Spreads, While WHO Says No Need For ‘Vaccine Passport’ Yet 15/01/2021 Madeleine Hoecklin & Kerry Cullinan Many areas of Brazil, particularly Manaus, are experiencing worsening COVID-19 outbreaks and extremely high levels of infections, amidst news of a new variant that is spreading in the country. Brazil joins countries around the world – including those in Europe, the Americas, and some parts of Africa – that are seeing spikes in cases and […] Continue reading -> COVID-19 Infection Provides Temporary Immunity, Though Not From Transmission, Says Study 15/01/2021 Raisa Santos Past COVID-19 infection may provide immunity for several months, but still leaves risk of transmission to others, a Public Health England (PHE) study has found. “This means even if you believe you already had the disease and are protected, you can be reassured it is highly unlikely you will develop severe infections but there is […] Continue reading -> Hundreds of Victims of Bhopal Gas Leak Tragedy Recruited To India’s Covaxin Clinical Trials – Civil Society Groups Say 14/01/2021 Menaka Rao DELHI, INDIA – In the last week of December 2020, Chanda Devi heard a truck roll into her neighborhood in North Bhopal, Central India. Residents were called outside by a voice, booming through loudspeakers. They were eligible to collect Rs 750 (about US$10) to receive a “corona vaccine”. The people said that they were recruiters, […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 James Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 James Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> New Vaccine Approach May Be Needed As ‘Natural’ Antibodies Fail to Recognise COVID-19 Variant in South Africa 21/01/2021 Kerry Cullinan CAPE TOWN – Scientists are concerned that antibodies that could detect SARS-CoV-2 in South Africa’s first wave will be less effective against a virus variant that first emerged here and is known as 501Y.V2. What’s worse, they still don’t know if brand new COVID-19 vaccines will work against the variant – which is deemed to […] Continue reading -> Pandemic Perils: How Battling One Deadly Disease May Intensify Risks From Others 21/01/2021 Jamie Bay Nishi The demands of fighting the COVID-19 pandemic are draining resources from global health research and development (R&D) programs and disrupting clinical trials and other work, presenting a potential post-pandemic scenario of a world more vulnerable to a host of infectious threats. That’s what our organization, the Global Health Technologies Coalition (GHTC), learned after conducting extensive, […] Continue reading -> ‘Bilateral Deals’ Confound COVAX Vaccine Delivery Plans; Independent Panel Slams Global & WHO Pandemic Response 18/01/2021 Kerry Cullinan “Escalating bilateral deals” between pharmaceutical companies and World Health Organization (WHO) member states have complicated the global body’s vaccine delivery platform, the COVAX Facility, a number of top WHO officials told the WHO’s Executive Board yesterday in the opening day of the EB’s 148th session, which focused largely on the pandemic. “Countries with bilateral deals […] Continue reading -> COVID-19 Cases Spike In Brazil As New Variant Spreads, While WHO Says No Need For ‘Vaccine Passport’ Yet 15/01/2021 Madeleine Hoecklin & Kerry Cullinan Many areas of Brazil, particularly Manaus, are experiencing worsening COVID-19 outbreaks and extremely high levels of infections, amidst news of a new variant that is spreading in the country. Brazil joins countries around the world – including those in Europe, the Americas, and some parts of Africa – that are seeing spikes in cases and […] Continue reading -> COVID-19 Infection Provides Temporary Immunity, Though Not From Transmission, Says Study 15/01/2021 Raisa Santos Past COVID-19 infection may provide immunity for several months, but still leaves risk of transmission to others, a Public Health England (PHE) study has found. “This means even if you believe you already had the disease and are protected, you can be reassured it is highly unlikely you will develop severe infections but there is […] Continue reading -> Hundreds of Victims of Bhopal Gas Leak Tragedy Recruited To India’s Covaxin Clinical Trials – Civil Society Groups Say 14/01/2021 Menaka Rao DELHI, INDIA – In the last week of December 2020, Chanda Devi heard a truck roll into her neighborhood in North Bhopal, Central India. Residents were called outside by a voice, booming through loudspeakers. They were eligible to collect Rs 750 (about US$10) to receive a “corona vaccine”. The people said that they were recruiters, […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 James Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Vaccine Approach May Be Needed As ‘Natural’ Antibodies Fail to Recognise COVID-19 Variant in South Africa 21/01/2021 Kerry Cullinan CAPE TOWN – Scientists are concerned that antibodies that could detect SARS-CoV-2 in South Africa’s first wave will be less effective against a virus variant that first emerged here and is known as 501Y.V2. What’s worse, they still don’t know if brand new COVID-19 vaccines will work against the variant – which is deemed to […] Continue reading -> Pandemic Perils: How Battling One Deadly Disease May Intensify Risks From Others 21/01/2021 Jamie Bay Nishi The demands of fighting the COVID-19 pandemic are draining resources from global health research and development (R&D) programs and disrupting clinical trials and other work, presenting a potential post-pandemic scenario of a world more vulnerable to a host of infectious threats. That’s what our organization, the Global Health Technologies Coalition (GHTC), learned after conducting extensive, […] Continue reading -> ‘Bilateral Deals’ Confound COVAX Vaccine Delivery Plans; Independent Panel Slams Global & WHO Pandemic Response 18/01/2021 Kerry Cullinan “Escalating bilateral deals” between pharmaceutical companies and World Health Organization (WHO) member states have complicated the global body’s vaccine delivery platform, the COVAX Facility, a number of top WHO officials told the WHO’s Executive Board yesterday in the opening day of the EB’s 148th session, which focused largely on the pandemic. “Countries with bilateral deals […] Continue reading -> COVID-19 Cases Spike In Brazil As New Variant Spreads, While WHO Says No Need For ‘Vaccine Passport’ Yet 15/01/2021 Madeleine Hoecklin & Kerry Cullinan Many areas of Brazil, particularly Manaus, are experiencing worsening COVID-19 outbreaks and extremely high levels of infections, amidst news of a new variant that is spreading in the country. Brazil joins countries around the world – including those in Europe, the Americas, and some parts of Africa – that are seeing spikes in cases and […] Continue reading -> COVID-19 Infection Provides Temporary Immunity, Though Not From Transmission, Says Study 15/01/2021 Raisa Santos Past COVID-19 infection may provide immunity for several months, but still leaves risk of transmission to others, a Public Health England (PHE) study has found. “This means even if you believe you already had the disease and are protected, you can be reassured it is highly unlikely you will develop severe infections but there is […] Continue reading -> Hundreds of Victims of Bhopal Gas Leak Tragedy Recruited To India’s Covaxin Clinical Trials – Civil Society Groups Say 14/01/2021 Menaka Rao DELHI, INDIA – In the last week of December 2020, Chanda Devi heard a truck roll into her neighborhood in North Bhopal, Central India. Residents were called outside by a voice, booming through loudspeakers. They were eligible to collect Rs 750 (about US$10) to receive a “corona vaccine”. The people said that they were recruiters, […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 James Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Pandemic Perils: How Battling One Deadly Disease May Intensify Risks From Others 21/01/2021 Jamie Bay Nishi The demands of fighting the COVID-19 pandemic are draining resources from global health research and development (R&D) programs and disrupting clinical trials and other work, presenting a potential post-pandemic scenario of a world more vulnerable to a host of infectious threats. That’s what our organization, the Global Health Technologies Coalition (GHTC), learned after conducting extensive, […] Continue reading -> ‘Bilateral Deals’ Confound COVAX Vaccine Delivery Plans; Independent Panel Slams Global & WHO Pandemic Response 18/01/2021 Kerry Cullinan “Escalating bilateral deals” between pharmaceutical companies and World Health Organization (WHO) member states have complicated the global body’s vaccine delivery platform, the COVAX Facility, a number of top WHO officials told the WHO’s Executive Board yesterday in the opening day of the EB’s 148th session, which focused largely on the pandemic. “Countries with bilateral deals […] Continue reading -> COVID-19 Cases Spike In Brazil As New Variant Spreads, While WHO Says No Need For ‘Vaccine Passport’ Yet 15/01/2021 Madeleine Hoecklin & Kerry Cullinan Many areas of Brazil, particularly Manaus, are experiencing worsening COVID-19 outbreaks and extremely high levels of infections, amidst news of a new variant that is spreading in the country. Brazil joins countries around the world – including those in Europe, the Americas, and some parts of Africa – that are seeing spikes in cases and […] Continue reading -> COVID-19 Infection Provides Temporary Immunity, Though Not From Transmission, Says Study 15/01/2021 Raisa Santos Past COVID-19 infection may provide immunity for several months, but still leaves risk of transmission to others, a Public Health England (PHE) study has found. “This means even if you believe you already had the disease and are protected, you can be reassured it is highly unlikely you will develop severe infections but there is […] Continue reading -> Hundreds of Victims of Bhopal Gas Leak Tragedy Recruited To India’s Covaxin Clinical Trials – Civil Society Groups Say 14/01/2021 Menaka Rao DELHI, INDIA – In the last week of December 2020, Chanda Devi heard a truck roll into her neighborhood in North Bhopal, Central India. Residents were called outside by a voice, booming through loudspeakers. They were eligible to collect Rs 750 (about US$10) to receive a “corona vaccine”. The people said that they were recruiters, […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 James Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
‘Bilateral Deals’ Confound COVAX Vaccine Delivery Plans; Independent Panel Slams Global & WHO Pandemic Response 18/01/2021 Kerry Cullinan “Escalating bilateral deals” between pharmaceutical companies and World Health Organization (WHO) member states have complicated the global body’s vaccine delivery platform, the COVAX Facility, a number of top WHO officials told the WHO’s Executive Board yesterday in the opening day of the EB’s 148th session, which focused largely on the pandemic. “Countries with bilateral deals […] Continue reading -> COVID-19 Cases Spike In Brazil As New Variant Spreads, While WHO Says No Need For ‘Vaccine Passport’ Yet 15/01/2021 Madeleine Hoecklin & Kerry Cullinan Many areas of Brazil, particularly Manaus, are experiencing worsening COVID-19 outbreaks and extremely high levels of infections, amidst news of a new variant that is spreading in the country. Brazil joins countries around the world – including those in Europe, the Americas, and some parts of Africa – that are seeing spikes in cases and […] Continue reading -> COVID-19 Infection Provides Temporary Immunity, Though Not From Transmission, Says Study 15/01/2021 Raisa Santos Past COVID-19 infection may provide immunity for several months, but still leaves risk of transmission to others, a Public Health England (PHE) study has found. “This means even if you believe you already had the disease and are protected, you can be reassured it is highly unlikely you will develop severe infections but there is […] Continue reading -> Hundreds of Victims of Bhopal Gas Leak Tragedy Recruited To India’s Covaxin Clinical Trials – Civil Society Groups Say 14/01/2021 Menaka Rao DELHI, INDIA – In the last week of December 2020, Chanda Devi heard a truck roll into her neighborhood in North Bhopal, Central India. Residents were called outside by a voice, booming through loudspeakers. They were eligible to collect Rs 750 (about US$10) to receive a “corona vaccine”. The people said that they were recruiters, […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 James Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVID-19 Cases Spike In Brazil As New Variant Spreads, While WHO Says No Need For ‘Vaccine Passport’ Yet 15/01/2021 Madeleine Hoecklin & Kerry Cullinan Many areas of Brazil, particularly Manaus, are experiencing worsening COVID-19 outbreaks and extremely high levels of infections, amidst news of a new variant that is spreading in the country. Brazil joins countries around the world – including those in Europe, the Americas, and some parts of Africa – that are seeing spikes in cases and […] Continue reading -> COVID-19 Infection Provides Temporary Immunity, Though Not From Transmission, Says Study 15/01/2021 Raisa Santos Past COVID-19 infection may provide immunity for several months, but still leaves risk of transmission to others, a Public Health England (PHE) study has found. “This means even if you believe you already had the disease and are protected, you can be reassured it is highly unlikely you will develop severe infections but there is […] Continue reading -> Hundreds of Victims of Bhopal Gas Leak Tragedy Recruited To India’s Covaxin Clinical Trials – Civil Society Groups Say 14/01/2021 Menaka Rao DELHI, INDIA – In the last week of December 2020, Chanda Devi heard a truck roll into her neighborhood in North Bhopal, Central India. Residents were called outside by a voice, booming through loudspeakers. They were eligible to collect Rs 750 (about US$10) to receive a “corona vaccine”. The people said that they were recruiters, […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 James Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVID-19 Infection Provides Temporary Immunity, Though Not From Transmission, Says Study 15/01/2021 Raisa Santos Past COVID-19 infection may provide immunity for several months, but still leaves risk of transmission to others, a Public Health England (PHE) study has found. “This means even if you believe you already had the disease and are protected, you can be reassured it is highly unlikely you will develop severe infections but there is […] Continue reading -> Hundreds of Victims of Bhopal Gas Leak Tragedy Recruited To India’s Covaxin Clinical Trials – Civil Society Groups Say 14/01/2021 Menaka Rao DELHI, INDIA – In the last week of December 2020, Chanda Devi heard a truck roll into her neighborhood in North Bhopal, Central India. Residents were called outside by a voice, booming through loudspeakers. They were eligible to collect Rs 750 (about US$10) to receive a “corona vaccine”. The people said that they were recruiters, […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 James Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Hundreds of Victims of Bhopal Gas Leak Tragedy Recruited To India’s Covaxin Clinical Trials – Civil Society Groups Say 14/01/2021 Menaka Rao DELHI, INDIA – In the last week of December 2020, Chanda Devi heard a truck roll into her neighborhood in North Bhopal, Central India. Residents were called outside by a voice, booming through loudspeakers. They were eligible to collect Rs 750 (about US$10) to receive a “corona vaccine”. The people said that they were recruiters, […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 James Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 James Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> Posts navigation Older posts